This subproject is one of many research subprojects utilizing theresources provided by a Center grant funded by NIH/NCRR. The subproject andinvestigator (PI) may have received primary funding from another NIH source,and thus could be represented in other CRISP entries. The institution listed isfor the Center, which is not necessarily the institution for the investigator.Driving Biological Project 2: Proteolytic Regulation of HIF-lalpha: An Ancient ProteasePathway Regulates the Von Hippel-Lindau Angiogenesis Network Patients with von Hippel-Lindau syndrome present with highly vascularized tumors of the CNS and theeye, because of a pro-angiogenic defect in the proteasome pathway. The von Hippel-Lindauprotein is part of an E3 ubiquitin-protein ligase complex. This complex targets hypoxia-induciblefactor (HIF)-1alpha for degradation. Our computational analysis of the Japanese pufferfish (Fugu rubripes)reveals an ancient fusion protein comprised of the von Hippel-Lindau protein, and two proteases,methionine aminopeptidase-2, and a LON-like protease. We plan to test the Rosetta stonehypothesis, namely that these three proteins are linked in a proteolytic network involved inregulating HIF-lalpha. Our work will include attempts to identify the substrates for each protease, andefforts to test their role in the HIF-lalpha pathway

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54RR020843-05
Application #
7725959
Study Section
Special Emphasis Panel (ZRG1-BST-D (55))
Project Start
2008-08-01
Project End
2009-07-31
Budget Start
2008-08-01
Budget End
2009-07-31
Support Year
5
Fiscal Year
2008
Total Cost
$76,018
Indirect Cost
Name
Sanford-Burnham Medical Research Institute
Department
Type
DUNS #
020520466
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Savinov, Alexei Y; Strongin, Alex Y (2013) Targeting the T-cell membrane type-1 matrix metalloproteinase-CD44 axis in a transferred type 1 diabetes model in NOD mice. Exp Ther Med 5:438-442
Moin, Kamiar; Sameni, Mansoureh; Victor, Bernadette C et al. (2012) 3D/4D functional imaging of tumor-associated proteolysis: impact of microenvironment. Methods Enzymol 506:175-94
Mueller, Kelly L; Madden, Julie M; Zoratti, Gina L et al. (2012) Fibroblast-secreted hepatocyte growth factor mediates epidermal growth factor receptor tyrosine kinase inhibitor resistance in triple-negative breast cancers through paracrine activation of Met. Breast Cancer Res 14:R104
Giordano, Courtney R; Mueller, Kelly L; Terlecky, Laura J et al. (2012) A targeted enzyme approach to sensitization of tyrosine kinase inhibitor-resistant breast cancer cells. Exp Cell Res 318:2014-21
Bush, Jason A; Kitaura, Hideki; Ma, Yuliang et al. (2012) Comparative proteomic analysis of a cytosolic fraction from ?3 integrin-deficient cells. Cancer Genomics Proteomics 9:1-13
Mullins, Stefanie R; Sameni, Mansoureth; Blum, Galia et al. (2012) Three-dimensional cultures modeling premalignant progression of human breast epithelial cells: role of cysteine cathepsins. Biol Chem 393:1405-16
Békés, Miklós; Prudden, John; Srikumar, Tharan et al. (2011) The dynamics and mechanism of SUMO chain deconjugation by SUMO-specific proteases. J Biol Chem 286:10238-47
Ren, Gang; Blum, Galia; Verdoes, Martijn et al. (2011) Non-invasive imaging of cysteine cathepsin activity in solid tumors using a 64Cu-labeled activity-based probe. PLoS One 6:e28029
Irwin, Mary E; Bohin, Natacha; Boerner, Julie L (2011) Src family kinases mediate epidermal growth factor receptor signaling from lipid rafts in breast cancer cells. Cancer Biol Ther 12:718-26
Zhu, Wenhong; Fang, Changming; Gramatikoff, Kosi et al. (2011) Proteins and an inflammatory network expressed in colon tumors. J Proteome Res 10:2129-39

Showing the most recent 10 out of 140 publications